The European Commission (EC) has already approved Valneva’s chikungunya vaccine Ixchiq for use in individuals aged 18 years ...
The world’s first vaccine for mosquito-borne chikungunya virus has been approved by the UK’s Medicines and Healthcare ...
A surge in respiratory and mosquito-borne illnesses drove an increase in health risks in 2024. COVID infections climbed, fueled by new variants like KP.3 and LB.1, though hospitalizations remained low ...
News Medical on MSN9d
NIH-funded clinical trial will evaluate new dengue therapeuticA clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help ...
This study presents a model framework for predicting near-term and future dengue mortalities in India for effective ...
To note, CHO recorded 12 chikungunya cases across various barangays in the city in 2024, which also included Barangay 9-A. While Chikungunya is not fatal, she stressed that keeping the surroundings ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Valneva’s single-dose chikungunya vaccine for use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback